Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders

Mitochondrion. 2016 Sep:30:51-8. doi: 10.1016/j.mito.2016.06.007. Epub 2016 Jun 30.

Abstract

We evaluated the coenzyme Q₁₀ (CoQ) levels in patients who were diagnosed with mitochondrial oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders (n=72). Data from the 72 cases in this study revealed that 44.4% of patients showed low CoQ concentrations in either their skeletal muscle or skin fibroblasts. Our findings suggest that secondary CoQ deficiency is a common finding in OXPHOS and non-OXPHOS disorders. We hypothesize that cases of CoQ deficiency associated with OXPHOS defects could be an adaptive mechanism to maintain a balanced OXPHOS, although the mechanisms explaining these deficiencies and the pathophysiological role of secondary CoQ deficiency deserves further investigation.

Keywords: Coenzyme Q(10); Mitochondrial respiratory chain; Muscle biopsy; Oxidative phosphorylation disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Mitochondrial Diseases / pathology*
  • Muscles / pathology
  • Oxidative Phosphorylation*
  • Prevalence
  • Skin / pathology
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / deficiency
  • Young Adult

Substances

  • Ubiquinone
  • coenzyme Q10